Skip to main content
Clinical Trials/NCT03713567
NCT03713567CompletedNot Applicable

Clinical, Immunological and Microbiological Evaluation of Experimental Gingivitis and Peri-implant Mucositis in Patients With History of Agressive Periodontal Disease

University of Campinas, Brazil2 sites in 1 country20 target enrollmentStarted: November 7, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20
Locations
2
Primary Endpoint
Changes of Modified Gingival Index in five different periods

Study Overview

Brief Summary

The objective of this study is to evaluate, through clinical, microbiological and immunological tests, the changes during the experimental gingivitis and mucositis model, between teeth and implants, and between patients with a history of aggressive periodontitis and healthy individuals.

Detailed Description

The objective of this study is to evaluate, through clinical, microbiological and immunological tests, the changes during the experimental gingivitis and mucositis model, between teeth and implants, and between patients with a history of aggressive periodontitis and healthy individuals. 20 patients will be include, 10 healthy and 10 with a history of aggressive periodontitis. All patients must present the same type of implant and abutments, with prostheses in function for more than 6 months. They should also have a tooth located in the contralateral hemi-arch in a similar position, allowing a comparison with the implant. They will be submitted to the plaque-induced inflammation by suspension of oral hygiene only in the tested areas (tooth / implant), protected by a personalized stent made of plastic, according to the experimental gingivitis and mucositis model of 21 days of duration.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Aged ≥ 18 years,
  • History of aggressive periodontitis diagnosed according to the Armitage classification (1999) and verified by the dental chart and time of radiographic bone emission, being in periodontal maintenance for a little more than 6 months (Test group).
  • Presence of teeth and implants (unitary prostheses) in the mouth; in a similar and counter-lateral position in the arch. The implants are the same system, including protective and dimensions.
  • Probing Depth <5mm, in the interest sites.
  • Plaque Index ≤ 20% (Silness & Löe, 1964),
  • Healthy patients
  • Signature of free and informed consent.

Exclusion Criteria

  • Probing Depth> 5mm, in the interest sites.
  • History of bone loss by peri-implantitis in the implant test.
  • Pregnancy;
  • Presence of systemic disorders (diabetes, hypertension, heart disease or any other condition that could contraindicate periodontal surgery);
  • Use of medications (immunosuppressants, phenytoin or anything else that might affect mucosal healing and repair);

Arms & Interventions

Experimentally induced plaque

Placebo Comparator

Induced inflammation by suspension of oral hygiene

Intervention: Experimentally induced plaque (Behavioral)

Experimentally induced plaque GAP

Experimental

Induced inflammation by suspension of oral hygiene in patients with history of Generalized Aggressive periodontitis

Intervention: Experimentally induced plaque (Behavioral)

Outcomes

Primary Outcomes

Changes of Modified Gingival Index in five different periods

Time Frame: Baseline, 7 days, 14 days, 21 days, 42 days

According to the method of Löe \& Silness (1963) without the bleeding in the component of prueba.Measure at each visit 0 - absence of inflammation; 1. - Light inflammation - slight color change and little alteration in gingival texture; 2. - Moderate inflammation - moderate texture change, redness, edema, hypertrophy. 3. - Severe inflammation - redness, hypertrophy.

Secondary Outcomes

  • Changes of Angulated Bleeding Index in five different periods(Baseline, 7 days, 14 days, 21 days, 42 days)
  • Changes of Plaque Index in five different periods(Baseline, 7 days, 14 days, 21 days, 42 days)

Investigators

Sponsor
University of Campinas, Brazil
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Enilson Antonio Sallum

Full Professor

University of Campinas, Brazil

Study Sites (2)

Loading locations...

Similar Trials

Clinical, Immunological and... | Clinical Trial